DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 189 filers reported holding DICERNA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $226,000 | -46.1% | 11,235 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $419,000 | +0.7% | 11,235 | -31.0% | 0.00% | -33.3% |
| Q1 2021 | $416,000 | +77.0% | 16,283 | +52.9% | 0.00% | +50.0% |
| Q4 2020 | $235,000 | +55.6% | 10,648 | +27.1% | 0.00% | +100.0% |
| Q3 2020 | $151,000 | -32.0% | 8,378 | -4.1% | 0.00% | -66.7% |
| Q2 2020 | $222,000 | +65.7% | 8,739 | +19.7% | 0.00% | +50.0% |
| Q1 2020 | $134,000 | +9.8% | 7,303 | +26.9% | 0.00% | 0.0% |
| Q4 2019 | $122,000 | -31.1% | 5,756 | -53.4% | 0.00% | -33.3% |
| Q3 2019 | $177,000 | +12.7% | 12,340 | +23.8% | 0.00% | 0.0% |
| Q2 2019 | $157,000 | -7.6% | 9,966 | -14.2% | 0.00% | -25.0% |
| Q1 2019 | $170,000 | +46.6% | 11,618 | +8.9% | 0.00% | +33.3% |
| Q4 2018 | $116,000 | -27.5% | 10,673 | +1.6% | 0.00% | 0.0% |
| Q3 2018 | $160,000 | – | 10,510 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,355,392 | $29,859,000 | 6.21% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $67,858,000 | 4.26% |
| DAFNA Capital Management LLC | 587,756 | $12,948,000 | 3.85% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 227,388 | $5,009,000 | 2.91% |
| RTW INVESTMENTS, LP | 7,253,857 | $159,802,000 | 2.68% |
| Parkman Healthcare Partners LLC | 331,513 | $7,303,000 | 1.87% |
| Evolutionary Tree Capital Management, LLC | 60,864 | $1,341,000 | 1.02% |
| Eagle Health Investments LP | 69,000 | $1,520,000 | 0.97% |
| Woodline Partners LP | 1,358,796 | $29,934,000 | 0.79% |
| Affinity Asset Advisors, LLC | 40,000 | $881,000 | 0.47% |